TRIB
Trinity Biotech
TRIB
TRIB
92 hedge funds and large institutions have $323M invested in Trinity Biotech in 2015 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 33 increasing their positions, 30 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
38% less call options, than puts
Call options by funds: $287K | Put options by funds: $466K
Holders
92
Holding in Top 10
2
Calls
$287K
Puts
$466K
Top Buyers
| 1 | +$9.48M | |
| 2 | +$8.29M | |
| 3 | +$5.38M | |
| 4 |
DM
Deerfield Management
New York
|
+$4.74M |
| 5 |
RFC
Russell Frank Company
Seattle,
Washington
|
+$4.2M |
Top Sellers
| 1 | -$7.17M | |
| 2 | -$5.74M | |
| 3 | -$1.29M | |
| 4 |
KCM
Keane Capital Management
Charlotte,
North Carolina
|
-$977K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$892K |